A clinical trial that gives drugs for one type of cancer to patients with another type of cancer may seem like a mix-and-match approach, but it’s actually a highly focused precision medicine initiative. The NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) trial assigns drugs according to the genetic abnormalities of cancer cells instead of the […]
C-H-O-L-A-N-G-I-O-C-A-R-C-I-N-O-M-A. Anne Wolfe asked the doctor to spell it out. She had come to see Kamran Idrees, M.D., a surgical oncologist at Vanderbilt-Ingram Cancer Center (VICC) knowing that she had a malignancy in her liver, but she didn’t know the type of cancer that had secretly invaded the organ. “He looked at me and said […]
Social worker Cindy Tinker Hancock, LMSW, imagines the internal monologues that pass through the minds of people she encounters at Vanderbilt-Ingram Cancer Center (VICC). “Wait a minute—how did this happen?” she wonders aloud, slipping into a patient’s shoes, “I have a stage IV diagnosis and I can’t work. “I need to apply for disability or […]
Preventing cancer, pioneering new cancer treatments and safeguarding patients from harm are missions that require community commitment. Vanderbilt-Ingram Cancer Center (VICC) is taking actions on all those fronts, but we can’t do it alone. The articles in this issue of Momentum highlight the importance of primary care providers, philanthropic supporters, empowered patients and emergency department […]
